|
JOURNALS
Park, CM; Bruncko, M; Adickes,
J; Bauch, J; Ding, H; Kunzer,
A; Marsh, KC; Nimmer, P; Shoemaker, AR; Song,
X; Tahir, SK; Wang, X; Wendt, MD; Yang, X;
Zhang, H; Fesik, S; Rosenberg, SH; Elmore, SW
“Discovery of an Orally Bioavailable Small
Molecule Inhibitor of Pro-survival B-cell Lymphoma 2 Proteins” J. Med. Chem. 2008, 51,
6902.
Bruncko, M; Oost, TK; Belli, BA; Ding, H; Joseph, MK; Kunzer, A; Martineau, D; McClellan, WJ; Mitten, M;
Ng, SC; Nimmer, PM; Oltersdorf,
T; Park, CM; Petros, AM; Shoemaker, AR;
Song, X; Wang, X; Wendt, MD; Zhang, H; Fesik, SW;
Rosenberg, SH; Elmore, SW “Studies Leading to Potent, Dual Inhibitors of
Bcl-2 and Bcl-XL” J. Med. Chem. 2007,
50, 641.
Park, CM; Oie, T; Petros,
AM; Zhang, H; Nimmer, PM; Henry, RF; Elmore, SW
“Design, Synthesis and Computational Studies of Inhibitors of Bcl Protein” J. Am. Chem. Soc. 2006,
128, 16206.
Park, CM “Concise Synthesis of 3,7-Dioxa-9-aza-bicyclo[3,3,1]-nonane” J. Org. Chem. 2006, 71,
413.
Lynch, JK; Park, CM “Syntheses of
Colombiasin A and Elisapterosin
B” Chemtracts: Organic Chemistry 2005,
18, 236.
Elmore, SW; Oost,
T; Park, CM “Inhibitors of Anti-apoptotic Proteins for Cancer
Therapy” Annual Reports in Medicinal Chemistry 2005, 40,
245.
Park, CM; Sun, C; Olejniczak, ET; Wilson, AE;
Meadows, RP; Betz, SF; Elmore, SW; Fesik, SW
“Non-peptidic small molecule inhibitors of
XIAP” Bioorg. Med.Chem.
Lett.
2005, 15, 771.
Wender, PA; Lippa, B; Park, CM; Irie,
K; Nakahara, A; Ohigashi, H “Selective Binding
of Bryostatin Analogues to the Cysteine Rich Domains of Protein Kinase
C Isozymes” Bioorg.
Med.Chem. Lett. 1999, 9, 1687.
Wender, PA; Brabander, JD; Harran, PG; Jimenez, JM; Koehler, MFT;
Lippa, B; Park, CM; Shiozaki,
M “Synthesis of the First Members of a New Class of Biologically Active Bryostatin Analogues” J. Am. Chem. Soc. 1998, 120, 4534.
Wender, PA; Brabander, JD; Harran, PG; Jimenez, JM; Koehler, MFT;
Lippa, B; Park, CM; Siedenbiedel,
C “The design, computer modelling, solution structure, and biological
evaluation of synthetic analogs of bryostatin 1” Proc. Natl. Acad. Sci. USA 1998,
95, 6624.
Wender, PA; Martin-Cantalejo, Y; Carpenter, AJ; Chiu, A; Brabander, JD; Harran, PG; Jimenez, JM; Koehler, MFT;
Lippa, B; Morrison, JA; Muller, SG; Muller, SN;
Park, CM; Shiozaki, M; Siedenbiedel, C; Skalitzky,
DJ; Tanaka, M; Irie, K “The chemistry-medicine continuum: synthetic, computer, spectroscopic and
biological studies on new chemotherapeutic leads” Pure Appl. Chem. 1998, 70, 539.
Lee, E; Park, CM;
Yoon, JS "Total Synthesis of Dactomelynes"
J. Am. Chem. Soc. 1995,
117, 8017.
Lee, E; Park, CM
"C-Furanoside Synthesis via Radical Cyclization
of b-Alkoxyacrylates"
J. Chem. Soc., Chem. Commun. 1994, 293.
Lee,
E; Tae, JS; Lee, C; Park, CM "b-Alkoxyacrylates
in Radical Cyclizations: Remarkably Efficient Oxacycle Synthesis" Tetrahedron Lett. 1993, 34, 4831.
Lee, E; Hur, CU; Park, CM "Synthesis of a-Methylene
d-valerolactones
and a-Methylenecyclohexanones
via Radical Cyclization of Propiolates
and Acetylenic Ketones"
Tetrahedron Lett. 1990, 31,
5039.
PATENTS
Elmore, SW; Souers, AJ; Bruncko, M; Song, X; Wang, X; Hasvold,
LA; Wang, L; Kunzer, AR; Park, CM; Wendt, MD; Tao, ZF “7-Substituted
indoles as Mcl-1 protein inhibitors and their
preparation” WO 2008/131000 A3
Bruncko, M; Ding, H; Elmore,
SW; Kunzer, AR; Lynch, CL; McClellan, WJ; Park, CM; Song, X; Wang, X
“Apoptosis Promoters” WO2007040650 A2
Bruncko, M; Elmore, SW; Park, CM; Kunzer,
A; Lynch, CL; Wang, X; Wendt, M; Ding, H; McClellan, W; Song, X; Tu, N; Petros, A “N-Acylsulfonamide Apoptosis Promoters” WO2005049594 A1
Elmore, SW; Park,
CM; Ding, H; Bruncko,
M “N-Sulfonylamidine Apoptosis Promoters” WO2005117543
A2
Elmore, SW; Park,
CM; Wang, X “N-Sulfonylurea
Apoptosis Promoters” US7030115 B2;
WO2003080586 A1; EP1487811 A1
Wender, PA; Lippa, B; Park, CM; Hinkle, KW “Synthesis of bryostatin
analogues for pharmaceutical use as anticancer agents” US2003220334 A1;
US2002137789 A1; WO0140214 A1
Wender, PA; Lippa, B; Park, CM; Hinkle, KW “Synthetic methods and uses of bryostatin
analogs” WO2003070719 A1
|